Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Elekta (EKTA-B.ST) announced today that Johan Adebäck has been appointed as permanent Chief Financial Officer with immediate effect. He has held the...
Elekta (EKTA-B.ST) announced today that several cancer centers are the early adopters of the company's first release in the MOSAIQ® 3* series....
Elekta (EKTA-B.ST) announced today that it has again been recognized as one of the World's Most Ethical Companies® by the Ethisphere Institute, a...
Elekta (EKTA-B.ST) announced today that it will establish a permanent office in Cairo, Egypt, to address the shortage of radiotherapy delivery...
Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the third quarter 2020/21 at 10:00 a.m. CET on February 25. The interim report ...
Elekta announced today that the United States Department of Veterans Affairs (VA) National Radiation Oncology Program is poised to pair its major...
Elekta (EKTA-B.ST) today announced that its MOSAIQ® Oncology Information System (OIS) and Versa HD™ linear accelerator have been named "Best in KLAS" ...
Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc....
During the European Society for Radiotherapy and Oncology (ESTRO) and American Society for Radiation Oncology (ASTRO) Annual Meetings, users of the...
Elekta (EKTA-B.ST) announced today that Gustaf Salford has been appointed to the role of President and CEO, effective immediately. He has been Acting ...
In Elekta's second quarter, we managed to perform better than the overall radiotherapy market both in terms of orders and revenue despite continuous...
Elekta (EKTA-B.ST) today introduced Elekta Studio with its launch of the ImagingRing, an advanced interventional CT system that revolves around the...
Elekta (EKTA-B.ST) announced today that its Geneva Universal Gynecological Applicator recently received U.S. FDA 510(k) clearance, enabling...
Elekta (EKTA-B.ST) announced today that they have been named one of the 2020 World's Most Ethical Companies® by Ethisphere, a global leader in...
Elekta (EKTA-B.ST) today announced that its Versa HD™ linear accelerator and MOSAIQ® Oncology Information System (OIS) have been selected as Category ...
Elekta (EKTA-B.ST) today announced that Hôpital Riviera-Chablais in Rennaz has treated the first patient in Switzerland using Elekta Unity MR-Linac,...
Elekta (EKTA-B.ST) and HEDY Group of Guangzhou, China, recently signed an agreement for 10 linear accelerators (linacs) as well as Monaco® treatment...
Elekta (EKTA-B.ST) today announced that it has received 510(k) premarket notification from the U.S. Food and Drug Administration for the use of...
Sweden's first-ever patient to be treated on the groundbreaking Elekta Unity MR-Linac radiation therapy system took place at Uppsala University...
The Technology Services Industry Association (TSIA) has presented Elekta (EKTA-B.ST) with its STAR award - a great honor in the technology services...
Elekta (EKTA-B.ST) announces that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has been awarded the Institute of Physics...
Elekta (EKTA-B.ST) today announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system was featured in 21 abstracts at the...
Elekta (EKTA-B.ST) has been awarded a group purchasing agreement for Full Line Radiation Oncology Products and Services with Premier. Effective...
Elekta (EKTA-B.ST) has signed a distribution agreement with DOSIsoft, a company that offers patient-specific quality assurance (QA) software, to be...
At the American Society for Radiation Oncology (ASTRO) 2019 Annual Meeting, September 15-18 in Chicago, Elekta (EKTA-B.ST) will highlight its growing ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.